Literature DB >> 10382936

Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions.

G Gaidano1, E Castaños-Velez, P Biberfeld.   

Abstract

Following the demonstration in 1994, that Kaposi's sarcoma (KS) was associated with a novel virus (KSHV or HHV-8) belonging to the lymphotropic herpes family, this virus was also found in certain lymphoid neoplasias of immunodeficient (HIV+) and immune competent hosts. The association of HHV-8/KSHV infection is now well established with primary effusion lymphoma (PEL) or body cavity based lymphoma (BCBL) and multicentric Castleman's disease (MCD) of the plasma cell type. A possible pathogenic role of HHV-8/KSHV in other lymphoid tumours including primary central nervous system lymphoma (PCNSL) and multiple myeloma (MM) as well as some atypical lymphoproliferations and sarcoidosis has also been suggested, but this is at present a controversial matter, or not confirmed. Several HHV-8/KSHV genes, including potential oncogenes, genes homologous to various cellular genes and growth factors have been incriminated in the pathogenesis of KS and PEL/BCBL, but a common pathogenic mechanism for the clearly diverse proliferations represented by PEL, MCD and KS is at present not evident.

Entities:  

Mesh:

Year:  1999        PMID: 10382936     DOI: 10.1007/bf02787352

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  51 in total

Review 1.  Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm.

Authors:  D S Karcher; S Alkan
Journal:  Hum Pathol       Date:  1997-07       Impact factor: 3.466

2.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

Authors:  R G Nador; E Cesarman; A Chadburn; D B Dawson; M Q Ansari; J Sald; D M Knowles
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

3.  Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma.

Authors:  R Masood; T Zheng; A Tupule; N Arora; L Chatlynne; M Handy; J Whitman
Journal:  Science       Date:  1997-12-12       Impact factor: 47.728

4.  Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene.

Authors:  S Muralidhar; A M Pumfery; M Hassani; M R Sadaie; M Kishishita; J N Brady; J Doniger; P Medveczky; L J Rosenthal
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen.

Authors:  G Gaidano; A Gloghini; V Gattei; M F Rossi; A M Cilia; C Godeas; M Degan; T Perin; V Canzonieri; D Aldinucci; G Saglio; A Carbone; A Pinto
Journal:  Blood       Date:  1997-12-15       Impact factor: 22.113

6.  Human herpesvirus 8 variants in sarcoid tissues.

Authors:  L Di Alberti; A Piattelli; L Artese; G Favia; S Patel; N Saunders; S R Porter; C M Scully; S L Ngui; C G Teo
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

7.  Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus.

Authors:  H Lee; R Veazey; K Williams; M Li; J Guo; F Neipel; B Fleckenstein; A Lackner; R C Desrosiers; J U Jung
Journal:  Nat Med       Date:  1998-04       Impact factor: 53.440

8.  Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus.

Authors:  A Chadburn; E Cesarman; R G Nador; Y F Liu; D M Knowles
Journal:  Cancer       Date:  1997-08-15       Impact factor: 6.860

Review 9.  Body-cavity-based lymphoma in an elderly AIDS-unrelated male.

Authors:  T Okada; H Katano; H Tsutsumi; T Kumakawa; M Sawabe; T Arai; S Mori; M Mori
Journal:  Int J Hematol       Date:  1998-06       Impact factor: 2.490

10.  Human herpesvirus-8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity.

Authors:  M Luppi; P Barozzi; A Maiorana; T Artusi; R Trovato; R Marasca; M Savarino; L Ceccherini-Nelli; G Torelli
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

View more
  7 in total

1.  Proliferation and apoptosis in the evolution of endemic and acquired immunodeficiency syndrome-related Kaposi's sarcoma.

Authors:  E Kaaya; E Castaños-Vélez; T Heiden; M Ekman; A I Catrina; J Kitinya; L Andersson; P Biberfeld
Journal:  Med Oncol       Date:  2000-11       Impact factor: 3.064

2.  The Itch ubiquitin ligase is required for KSHV RTA induced vFLIP degradation.

Authors:  Jennifer C Chmura; Kevin Herold; Ayana Ruffin; Trudymae Atuobi; Yetunde Fabiyi; Ashley E Mitchell; Young Bong Choi; Elana S Ehrlich
Journal:  Virology       Date:  2016-11-30       Impact factor: 3.616

3.  Identification and Function of MicroRNAs Encoded by Herpesviruses.

Authors:  Zhi-Qiang Bai; Xiu-Fen Lei; Lin-Ding Wang; Shou-Jiang Gao
Journal:  Virol Sin       Date:  2008-12-01       Impact factor: 4.327

4.  KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development.

Authors:  Pawan Pyakurel; Fatemeh Pak; Amos R Mwakigonja; Ephata Kaaya; Peter Biberfeld
Journal:  Infect Agent Cancer       Date:  2007-02-02       Impact factor: 2.965

5.  The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.

Authors:  M Djerbi; V Screpanti; A I Catrina; B Bogen; P Biberfeld; A Grandien
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

6.  Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions.

Authors:  Amos R Mwakigonja; Pawan Pyakurel; Parviz Kokhaei; Fatemeh Pak; Leonard K Lema; Ephata E Kaaya; Peter Biberfeld
Journal:  Infect Agent Cancer       Date:  2008-06-30       Impact factor: 2.965

Review 7.  Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies.

Authors:  Eleonora Ruocco; Vincenzo Ruocco; Maria Lina Tornesello; Alessio Gambardella; Ronni Wolf; Franco M Buonaguro
Journal:  Clin Dermatol       Date:  2013 Jul-Aug       Impact factor: 3.541

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.